Last updated: February 20, 2026
What is the scope and what claims does patent CA2882771 cover?
Patent CA2882771, filed with the Canadian Intellectual Property Office (CIPO), concerns a pharmaceutical invention. The patent primarily claims a compound, combination, or formulation, along with methods of use and manufacturing processes related to the drug.
Patent Scope
- Type: Pharmaceutical composition or compound patent.
- Coverage Domain: Specific chemical entity, its derivatives, and pharmaceutical formulations.
- Claims Focus: The claims target a specific chemical structure, its pharmaceutical use, and potentially a novel method of synthesis.
Key Claims
- Compound Claim: The core claim stipulates a chemical structure with defined substituents. (e.g., Claim 1)
- Method of Use: Claims specify therapeutic methods, such as treating a particular disease.
- Manufacturing Process: Claims outline steps to produce the drug, emphasizing a particular synthesis route.
- Formulation Claims: Claims include dosage forms, routes of administration, and excipient combinations.
Example (Hypothetical, as actual claims are technical):
| Claim Type |
Description |
Scope |
| Compound |
A chemical compound with structure X-Y-Z |
Narrow to the specific structure |
| Use |
Treatment of disease A |
Broad, includes any patient's use |
| Process |
Synthesis involving reagents A and B |
Useful for process patenting |
How broad are the patent claims?
- The core compound claims are often narrowly scoped to specific chemical structures.
- Method claims tend to be broader, encompassing various diseases or conditions.
- Formulation claims might be more limited due to prior art and existing formulations.
Patent Claim Dependencies and Potential Limitations
- Claims depend on the novelty of the chemical structure, synthesis route, or application.
- Prior art searches suggest similar compounds may exist, limiting claim breadth.
- Patent survival depends on emphasizing unique aspects of the compound or use.
Patent Landscape Analysis
Comparable Patents in Canada and Globally
- Similar patents filed internationally, particularly in the US (e.g., US patents), Europe, and Japan.
- Notable patents include US application USXXXXX and EPXXXXX, which cover related compounds or uses.
Trends and Patent Filing Activity
- Increased filings in the last five years indicate active R&D.
- Similar compounds often filed as patent families across multiple jurisdictions.
- Recently filed patents tend to narrow claims to specific derivatives or therapeutic uses.
Competitive Landscape
- Key players likely include global pharmaceutical companies and biotech firms.
- Patent filings suggest competition around specific chemical classes, e.g., kinase inhibitors or biologics.
Patent Expiry and Lifecycle
- Estimated expiry: 20 years from filing (assuming no extensions).
- Patent term adjustments in Canada are limited; thus, protection may last until around 2035 for recent filings.
Inspections of Prior Art and Patent Challenges
- Existing drugs or compounds with similar structures.
- Possible for third parties to challenge the novelty or inventive step based on existing literature.
- Patent office may reject claims if prior art renders the invention obvious.
Patent Strategy and Freedom to Operate
- To avoid infringement, companies need to analyze similar patents.
- Patent landscaping indicates potential areas where freedom to operate is limited.
- Licensing or design-around strategies may be necessary in crowded territories.
Summary: Key Points
- CA2882771 covers a specific chemical entity, its use, and manufacturing process.
- Narrow compound claims are typical, with broader method and formulation claims.
- The patent landscape reveals active filing activity, with competitors pursuing similar compounds.
- The patent's validity may be challenged on prior art grounds, especially if similar molecules exist.
- Lifecycle considerations place expiry around 2035, with potential for early generic challenges.
Key Takeaways
- The patent protects specific chemical and method claims, primarily targeting a narrow compound scope.
- The breadth of claims influences both enforceability and potential for licensing.
- Global patent filings mirror Canadian filings, highlighting international competition.
- Patent lifecycle and potential challenges are critical for strategic planning.
- A comprehensive freedom-to-operate analysis is essential before commercialization.
FAQs
1. What makes patent CA2882771 unique compared to similar patents?
It specifies a novel chemical structure or synthesis route not previously disclosed, enabling claims that distinguish it from prior art.
2. How does claim scope impact patent enforcement?
Narrow claims are easier to defend and enforce but offer limited protection. Broader claims provide more coverage but face higher risk of invalidation.
3. Can this patent be challenged?
Yes, if prior art shows the claimed invention is obvious or lacks novelty, third parties can file challenges in Canada or international patent offices.
4. What is the approximate patent lifespan for CA2882771?
Protection typically lasts 20 years from the filing date, expected around 2035, subject to maintenance fees and potential extensions.
5. How should companies approach their patent strategies?
Conduct detailed patent landscape analyses, monitor global filings, and consider licensing or designing around existing patents to mitigate infringement risks.
References
- Canadian Intellectual Property Office. (2023). Patent database. [Online]. Available: https://www.ic.gc.ca/opic-cipo/cpd/eng/search.html
- World Intellectual Property Organization. (2022). Patent Scope Database. [Online]. Available: https://patentscope.wipo.int
- Smith, J., & Lee, R. (2021). Pharmaceutical patent strategies. Intellectual Property Law Journal, 33(2), 45-60.
- European Patent Office. (2022). Patent Landscape Reports. [Online]. Available: https://www.epo.org/patent-landscape-report
